POSTN and asthma: It is extremely important to take clinical features into consideration when managing patients with asthma at different GINA steps, particularly at GINA step 5, because several inflammatory biomarkers used to predict a good therapeutic response to the biologic treatment, such as FeNO and periostin, are not always available in all hospitals or areas/countries.